352 related articles for article (PubMed ID: 22578787)
1. Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease.
Karve S; Candrilli S; Kappelman MD; Tolleson-Rinehart S; Tennis P; Andrews E
J Pediatr; 2012 Oct; 161(4):662-670.e2. PubMed ID: 22578787
[TBL] [Abstract][Full Text] [Related]
2. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
3. Risks, subtypes, and hospitalization costs of stroke among patients with systemic lupus erythematosus: a retrospective cohort study in Taiwan.
Wang IK; Muo CH; Chang YC; Liang CC; Lin SY; Chang CT; Yen TH; Chuang FR; Chen PC; Huang CC; Sung FC
J Rheumatol; 2012 Aug; 39(8):1611-8. PubMed ID: 22753653
[TBL] [Abstract][Full Text] [Related]
4. Resource utilization and direct medical costs in adult systemic lupus erythematosus patients from a commercially insured population.
Furst DE; Clarke A; Fernandes AW; Bancroft T; Gajria K; Greth W; Iorga SR
Lupus; 2013 Mar; 22(3):268-78. PubMed ID: 23340996
[TBL] [Abstract][Full Text] [Related]
5. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes.
Oglesby A; Korves C; Laliberté F; Dennis G; Rao S; Suthoff ED; Wei R; Duh MS
Appl Health Econ Health Policy; 2014 Apr; 12(2):179-90. PubMed ID: 24573911
[TBL] [Abstract][Full Text] [Related]
6. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.
Garris C; Jhingran P; Bass D; Engel-Nitz NM; Riedel A; Dennis G
J Med Econ; 2013; 16(5):667-77. PubMed ID: 23425294
[TBL] [Abstract][Full Text] [Related]
7. Long-term medical costs and resource utilization in systemic lupus erythematosus and lupus nephritis: a five-year analysis of a large medicaid population.
Li T; Carls GS; Panopalis P; Wang S; Gibson TB; Goetzel RZ
Arthritis Rheum; 2009 Jun; 61(6):755-63. PubMed ID: 19479688
[TBL] [Abstract][Full Text] [Related]
8. Risk of sudden sensorineural hearing loss in patients with systemic lupus erythematosus: a population-based cohort study.
Lin C; Lin SW; Weng SF; Lin YS
Audiol Neurootol; 2013; 18(2):95-100. PubMed ID: 23257626
[TBL] [Abstract][Full Text] [Related]
9. A structured literature review of the direct costs of adult systemic lupus erythematosus in the US.
Slawsky KA; Fernandes AW; Fusfeld L; Manzi S; Goss TF
Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1224-32. PubMed ID: 21584945
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of systemic lupus erythematosus flares and comorbidities in a commercially insured population in the United States.
Narayanan S; Wilson K; Ogelsby A; Juneau P; Durden E
J Occup Environ Med; 2013 Nov; 55(11):1262-70. PubMed ID: 24202242
[TBL] [Abstract][Full Text] [Related]
11. Association of paediatric inflammatory bowel disease with other immune-mediated diseases.
Kappelman MD; Galanko JA; Porter CQ; Sandler RS
Arch Dis Child; 2011 Nov; 96(11):1042-6. PubMed ID: 21903597
[TBL] [Abstract][Full Text] [Related]
12. Health and economic burden of metabolic comorbidity among individuals with bipolar disorder.
Centorrino F; Mark TL; Talamo A; Oh K; Chang J
J Clin Psychopharmacol; 2009 Dec; 29(6):595-600. PubMed ID: 19910727
[TBL] [Abstract][Full Text] [Related]
13. Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States.
Kariburyo F; Xie L; Sah J; Li N; Lofland JH
J Med Econ; 2020 Jan; 23(1):1-9. PubMed ID: 31589081
[No Abstract] [Full Text] [Related]
14. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.
Joish VN; Spilsbury-Cantalupo M; Operschall E; Luong B; Boklage S
Appl Health Econ Health Policy; 2013 Jun; 11(3):299-304. PubMed ID: 23580074
[TBL] [Abstract][Full Text] [Related]
15. The burden of chronic low back pain: clinical comorbidities, treatment patterns, and health care costs in usual care settings.
Gore M; Sadosky A; Stacey BR; Tai KS; Leslie D
Spine (Phila Pa 1976); 2012 May; 37(11):E668-77. PubMed ID: 22146287
[TBL] [Abstract][Full Text] [Related]
16. Burden of illness in idiopathic pulmonary fibrosis.
Collard HR; Ward AJ; Lanes S; Cortney Hayflinger D; Rosenberg DM; Hunsche E
J Med Econ; 2012; 15(5):829-35. PubMed ID: 22455577
[TBL] [Abstract][Full Text] [Related]
17. Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study.
Miyazaki C; Sruamsiri R; Mahlich J; Jung W
J Med Econ; 2020 Jul; 23(7):786-799. PubMed ID: 32149541
[No Abstract] [Full Text] [Related]
18. Medical costs and healthcare resource use in patients with lupus nephritis and neuropsychiatric lupus in an insured population.
Furst DE; Clarke A; Fernandes AW; Bancroft T; Gajria K; Greth W; Iorga SR
J Med Econ; 2013; 16(4):500-9. PubMed ID: 23363329
[TBL] [Abstract][Full Text] [Related]
19. Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan.
Chiu YM; Lai CH
Lupus; 2010 Sep; 19(10):1250-5. PubMed ID: 20647248
[TBL] [Abstract][Full Text] [Related]
20. Health care resource utilization in inflammatory bowel disease.
Longobardi T; Bernstein CN
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):731-43. PubMed ID: 16631415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
